{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:30:06Z","timestamp":1777519806608,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T00:00:00Z","timestamp":1459382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81372832"],"award-info":[{"award-number":["81372832"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81302330"],"award-info":[{"award-number":["81302330"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the National Key Technology Research and Development Program of the Ministry of Science and Technology of China","award":["2014BAI09B08"],"award-info":[{"award-number":["2014BAI09B08"]}]},{"name":"the 973 project","award":["2013CB911004"],"award-info":[{"award-number":["2013CB911004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s10549-016-3766-3","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T10:29:10Z","timestamp":1459420150000},"page":"441-445","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations"],"prefix":"10.1007","volume":"156","author":[{"given":"Lu","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingjian","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoqing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tie","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benyao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuntao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,31]]},"reference":[{"issue":"5182","key":"3766_CR1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266(5182):66\u201371","journal-title":"Science"},{"issue":"5181","key":"3766_CR2","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1126\/science.8091231","volume":"265","author":"R Wooster","year":"1994","unstructured":"Wooster R, Neuhausen SL, Mangion J et al (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265(5181):2088\u20132090","journal-title":"Science"},{"issue":"1","key":"3766_CR3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000376600","volume":"10","author":"C Engel","year":"2015","unstructured":"Engel C, Fischer C (2015) Breast cancer risks and risk prediction models. Breast Care (Basel) 10(1):7\u201312. doi: 10.1159\/000376600","journal-title":"Breast Care (Basel)"},{"issue":"5","key":"3766_CR4","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117\u20131130. doi: 10.1086\/375033","journal-title":"Am J Hum Genet"},{"issue":"11","key":"3766_CR5","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25(11):1329\u20131333. doi: 10.1200\/JCO.2006.09.1066","journal-title":"J Clin Oncol"},{"issue":"1","key":"3766_CR6","first-page":"265","volume":"56","author":"DF Easton","year":"1995","unstructured":"Easton DF, Ford D, Bishop DT (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast cancer linkage consortium. Am J Hum Genet 56(1):265\u2013271","journal-title":"Am J Hum Genet"},{"issue":"20","key":"3766_CR7","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","volume":"336","author":"JP Struewing","year":"1997","unstructured":"Struewing JP, Hartge P, Wacholder S et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336(20):1401\u20131408. doi: 10.1056\/NEJM199705153362001","journal-title":"N Engl J Med"},{"issue":"3","key":"3766_CR8","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am J Hum Genet 62(3):676\u2013689","journal-title":"Am J Hum Genet"},{"issue":"1","key":"3766_CR9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1086\/301903","volume":"63","author":"FH Fodor","year":"1998","unstructured":"Fodor FH, Weston A, Bleiweiss IJ et al (1998) Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients. Am J Hum Genet 63(1):45\u201351. doi: 10.1086\/301903","journal-title":"Am J Hum Genet"},{"issue":"9","key":"3766_CR10","first-page":"741","volume":"8","author":"JL Hopper","year":"1999","unstructured":"Hopper JL, Southey MC, Dite GS et al (1999) Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian breast cancer family study. Cancer Epidemiol Biomarkers Prev 8(9):741\u2013747","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5645","key":"3766_CR11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"MC King","year":"2003","unstructured":"King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643\u2013646. doi: 10.1126\/science.1088759","journal-title":"Science"},{"issue":"3","key":"3766_CR12","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","volume":"68","author":"HA Risch","year":"2001","unstructured":"Risch HA, McLaughlin JR, Cole DE et al (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68(3):700\u2013710. doi: 10.1086\/318787","journal-title":"Am J Hum Genet"},{"issue":"11","key":"3766_CR13","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djt095","volume":"105","author":"N Mavaddat","year":"2013","unstructured":"Mavaddat N, Peock S, Frost D et al (2013) Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst 105(11):812\u2013822. doi: 10.1093\/jnci\/djt095","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"3766_CR14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/jnci\/djj012","volume":"98","author":"L Tryggvadottir","year":"2006","unstructured":"Tryggvadottir L, Sigvaldason H, Olafsdottir GH et al (2006) Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920\u20132000. J Natl Cancer Inst 98(2):116\u2013122. doi: 10.1093\/jnci\/djj012","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"3766_CR15","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrc2054","volume":"7","author":"JD Fackenthal","year":"2007","unstructured":"Fackenthal JD, Olopade OI (2007) Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer 7(12):937\u2013948. doi: 10.1038\/nrc2054","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"3766_CR16","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1054\/bjoc.2000.1407","volume":"83","author":"Anglian Breast Cancer Study Group","year":"2000","unstructured":"Anglian Breast Cancer Study Group (2000) Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer 83(10):1301\u20131308. doi: 10.1054\/bjoc.2000.1407","journal-title":"Br J Cancer"},{"issue":"7","key":"3766_CR17","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/jmg.2004.024133","volume":"42","author":"AC Antoniou","year":"2005","unstructured":"Antoniou AC, Pharoah PD, Narod S et al (2005) Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet 42(7):602\u2013603. doi: 10.1136\/jmg.2004.024133","journal-title":"J Med Genet"},{"issue":"2","key":"3766_CR18","first-page":"194","volume":"299","author":"CB Begg","year":"2008","unstructured":"Begg CB, Haile RW, Borg A et al (2008) Variation of breast cancer risk among BRCA1\/2 carriers. JAMA 299(2):194\u2013201. doi: 10.1001\/jama.2007.55-a","journal-title":"JAMA"},{"key":"3766_CR19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1471-2407-8-155","volume":"8","author":"DG Evans","year":"2008","unstructured":"Evans DG, Shenton A, Woodward E et al (2008) Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a clinical cancer genetics service setting: risks of breast\/ovarian cancer quoted should reflect the cancer burden in the family. BMC Cancer 8:155. doi: 10.1186\/1471-2407-8-155","journal-title":"BMC Cancer"},{"issue":"24","key":"3766_CR20","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1093\/jnci\/djq443","volume":"102","author":"K Metcalfe","year":"2010","unstructured":"Metcalfe K, Lubinski J, Lynch HT et al (2010) Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations. J Natl Cancer Inst 102(24):1874\u20131878. doi: 10.1093\/jnci\/djq443","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"3766_CR21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/(SICI)1098-2272(200002)18:2<173::AID-GEPI6>3.0.CO;2-R","volume":"18","author":"AC Antoniou","year":"2000","unstructured":"Antoniou AC, Gayther SA, Stratton JF et al (2000) Risk models for familial ovarian and breast cancer. Genet Epidemiol 18(2):173\u2013190. doi: 10.1002\/(SICI)1098-2272(200002)18:2<173:AID-GEPI6>3.0.CO;2-R","journal-title":"Genet Epidemiol"},{"issue":"3","key":"3766_CR22","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10549-015-3495-z","volume":"152","author":"B Park","year":"2015","unstructured":"Park B, Dowty JG, Ahn C et al (2015) Breast cancer risk for Korean women with germline mutations in BRCA1 and BRCA2. Breast Cancer Res Treat 152(3):659\u2013665. doi: 10.1007\/s10549-015-3495-z","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"3766_CR23","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1016\/S1470-2045(13)70567-9","volume":"15","author":"L Fan","year":"2014","unstructured":"Fan L, Strasser-Weippl K, Li JJ et al (2014) Breast cancer in China. Lancet Oncol 15(7):e279\u2013e289. doi: 10.1016\/S1470-2045(13)70567-9","journal-title":"Lancet Oncol"},{"issue":"2","key":"3766_CR24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1158\/1055-9965.EPI-03-0196","volume":"13","author":"NM Suter","year":"2004","unstructured":"Suter NM, Ray RM, Hu YW et al (2004) BRCA1 and BRCA2 mutations in women from Shanghai China. Cancer Epidemiol Biomarkers Prev 13(2):181\u2013189","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"3766_CR25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10549-007-9708-3","volume":"110","author":"WF Li","year":"2008","unstructured":"Li WF, Hu Z, Rao NY et al (2008) The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Breast Cancer Res Treat 110(1):99\u2013109. doi: 10.1007\/s10549-007-9708-3","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"3766_CR26","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10549-011-1596-x","volume":"132","author":"J Zhang","year":"2012","unstructured":"Zhang J, Pei R, Pang Z et al (2012) Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer. Breast Cancer Res Treat 132(2):421\u2013428. doi: 10.1007\/s10549-011-1596-x","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"3766_CR27","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/87876","volume":"7","author":"KL Nathanson","year":"2001","unstructured":"Nathanson KL, Wooster R, Weber BL (2001) Breast cancer genetics: what we know and what we need. Nat Med 7(5):552\u2013556. doi: 10.1038\/87876","journal-title":"Nat Med"},{"issue":"1","key":"3766_CR28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10549-008-0066-6","volume":"117","author":"W Chen","year":"2009","unstructured":"Chen W, Pan K, Ouyang T et al (2009) BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer. Breast Cancer Res Treat 117(1):55\u201360. doi: 10.1007\/s10549-008-0066-6","journal-title":"Breast Cancer Res Treat"},{"key":"3766_CR29","author":"A Kwong","year":"2015","unstructured":"Kwong A, Shin VY, Ho JC et al (2015) Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries. J Med Genet. doi: 10.1136\/jmedgenet-2015-103132","journal-title":"J Med Genet"},{"issue":"13","key":"3766_CR30","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/jama.2014.5985","volume":"313","author":"TR Rebbeck","year":"2015","unstructured":"Rebbeck TR, Mitra N, Wan F et al (2015) Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA 313(13):1347\u20131361. doi: 10.1001\/jama.2014.5985","journal-title":"JAMA"},{"issue":"1","key":"3766_CR31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.0006-341X.2001.00245.x","volume":"57","author":"N Chatterjee","year":"2001","unstructured":"Chatterjee N, Wacholder S (2001) A marginal likelihood approach for estimating penetrance from kin-cohort designs. Biometrics 57(1):245\u2013252","journal-title":"Biometrics"},{"issue":"12","key":"3766_CR32","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/jnci\/djs221","volume":"104","author":"B Mukherjee","year":"2012","unstructured":"Mukherjee B, Delancey JO, Raskin L et al (2012) Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers. J Natl Cancer Inst 104(12):953\u2013956. doi: 10.1093\/jnci\/djs221","journal-title":"J Natl Cancer Inst"},{"issue":"9137","key":"3766_CR33","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0140-6736(98)03300-5","volume":"352","author":"S Thorlacius","year":"1998","unstructured":"Thorlacius S, Struewing JP, Hartge P et al (1998) Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet 352(9137):1337\u20131339","journal-title":"Lancet"},{"issue":"14","key":"3766_CR34","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/jnci\/91.14.1241","volume":"91","author":"E Warner","year":"1999","unstructured":"Warner E, Foulkes W, Goodwin P et al (1999) Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Inst 91(14):1241\u20131247","journal-title":"J Natl Cancer Inst"},{"issue":"23","key":"3766_CR35","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/jnci\/djj465","volume":"98","author":"HA Risch","year":"2006","unstructured":"Risch HA, McLaughlin JR, Cole DE et al (2006) Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 98(23):1694\u20131706. doi: 10.1093\/jnci\/djj465","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"3766_CR36","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10549-004-2171-5","volume":"89","author":"RC Millikan","year":"2005","unstructured":"Millikan RC, Hummer AJ, Wolff MS et al (2005) HER2 codon 655 polymorphism and breast cancer: results from kin-cohort and case\u2013control analyses. Breast Cancer Res Treat 89(3):309\u2013312. doi: 10.1007\/s10549-004-2171-5","journal-title":"Breast Cancer Res Treat"},{"key":"3766_CR37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2407-4-9","volume":"4","author":"AJ Sigurdson","year":"2004","unstructured":"Sigurdson AJ, Hauptmann M, Chatterjee N et al (2004) Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes. BMC Cancer 4:9. doi: 10.1186\/1471-2407-4-9","journal-title":"BMC Cancer"},{"issue":"1","key":"3766_CR38","first-page":"41","volume":"30","author":"AH Hashemian","year":"2009","unstructured":"Hashemian AH, Hajizadeh E, Kazemnejad A et al (2009) Penetrance of BRCA1\/BRCA2 specific gene mutations in Iranian women with breast cancer. Saudi Med J 30(1):41\u201344","journal-title":"Saudi Med J"},{"key":"3766_CR39","volume-title":"Beijing municipal health and population health report","author":"Beijing Municipal People\u2019s Government","year":"2013","unstructured":"Beijing Municipal People\u2019s Government (2013) Beijing municipal health and population health report. People\u2019s Medical Publishing House, Beijing"},{"issue":"2","key":"3766_CR40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nrc726","volume":"2","author":"SA Narod","year":"2002","unstructured":"Narod SA (2002) Modifiers of risk of hereditary breast and ovarian cancer. Nat Rev Cancer 2(2):113\u2013123. doi: 10.1038\/nrc726","journal-title":"Nat Rev Cancer"},{"issue":"16","key":"3766_CR41","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jnci\/94.16.1221","volume":"94","author":"CB Begg","year":"2002","unstructured":"Begg CB (2002) On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 94(16):1221\u20131226","journal-title":"J Natl Cancer Inst"},{"issue":"8899","key":"3766_CR42","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","volume":"343","author":"D Ford","year":"1994","unstructured":"Ford D, Easton DF, Bishop DT et al (1994) Risks of cancer in BRCA1-mutation carriers. Breast cancer linkage consortium. Lancet 343(8899):692\u2013695","journal-title":"Lancet"},{"issue":"3","key":"3766_CR43","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10689-012-9531-9","volume":"11","author":"MA Bruin de","year":"2012","unstructured":"de Bruin MA, Kwong A, Goldstein BA et al (2012) Breast cancer risk factors differ between Asian and white women with BRCA1\/2 mutations. Fam Cancer 11(3):429\u2013439. doi: 10.1007\/s10689-012-9531-9","journal-title":"Fam Cancer"},{"issue":"3","key":"3766_CR44","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10549-010-0805-3","volume":"124","author":"DM Kolk van der","year":"2010","unstructured":"van der Kolk DM, de Bock GH, Leegte BK et al (2010) Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age. Breast Cancer Res Treat 124(3):643\u2013651. doi: 10.1007\/s10549-010-0805-3","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"3766_CR45","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/M13-1684","volume":"160","author":"HD Nelson","year":"2014","unstructured":"Nelson HD, Pappas M, Zakher B et al (2014) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. preventive services task force recommendation. Ann Intern Med 160(4):255\u2013266. doi: 10.7326\/M13-1684","journal-title":"Ann Intern Med"},{"issue":"9","key":"3766_CR46","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1245\/s10434-007-9447-z","volume":"14","author":"AE Giuliano","year":"2007","unstructured":"Giuliano AE, Boolbol S, Degnim A et al (2007) Society of surgical oncology: position statement on prophylactic mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007. Ann Surg Oncol 14(9):2425\u20132427. doi: 10.1245\/s10434-007-9447-z","journal-title":"Ann Surg Oncol"},{"issue":"21","key":"3766_CR47","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/jnci\/93.21.1633","volume":"93","author":"LC Hartmann","year":"2001","unstructured":"Hartmann LC, Sellers TA, Schaid DJ et al (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93(21):1633\u20131637","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"3766_CR48","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMra1503523","volume":"374","author":"LC Hartmann","year":"2016","unstructured":"Hartmann LC, Lindor NM (2016) The role of risk-reducing surgery in hereditary breast and ovarian cancer. N Engl J Med 374(5):454\u2013468. doi: 10.1056\/NEJMra1503523","journal-title":"N Engl J Med"},{"issue":"12","key":"3766_CR49","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/S0959-8049(98)00288-3","volume":"34","author":"HF Vasen","year":"1998","unstructured":"Vasen HF, Haites NE, Evans DG et al (1998) Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group. Eur J Cancer 34(12):1922\u20131926","journal-title":"Eur J Cancer"},{"issue":"6","key":"3766_CR50","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2105\/AJPH.85.6.801","volume":"85","author":"F Houn","year":"1995","unstructured":"Houn F, Helzlsouer KJ, Friedman NB et al (1995) The practice of prophylactic mastectomy: a survey of Maryland surgeons. Am J Public Health 85(6):801\u2013805","journal-title":"Am J Public Health"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3766-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-016-3766-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3766-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T12:43:20Z","timestamp":1559220200000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-016-3766-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,31]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["3766"],"URL":"https:\/\/doi.org\/10.1007\/s10549-016-3766-3","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,31]]}}}